| P50 | author | Bernard Séguin | Q56949752 |
| P2093 | author name string | Cheryl A London | |
| P2860 | cites work | Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis | Q22001442 |
| | Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 |
| | Mast cells as sentinels of innate immunity | Q33536530 |
| | Gastrointestinal stromal tumors: recent advances in understanding of their biology | Q33759344 |
| | The biology of stem cell factor and its receptor C-kit | Q33785129 |
| | Visceral mast cell tumors in dogs: 10 cases (1982-1997). | Q33887943 |
| | Kit signal transduction | Q33979008 |
| | Mast cell lineage development and phenotypic regulation | Q34264283 |
| | Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy | Q34264313 |
| | Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor | Q34567286 |
| | KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors | Q35809846 |
| | Skin Tumors in Domestic Animals. Data from 12 United States and Canadian Colleges of Veterinary Medicine 2 | Q36527186 |
| | Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor | Q37552904 |
| | Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit | Q40959621 |
| | Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms | Q40973424 |
| | Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior | Q40987642 |
| | Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors | Q41195491 |
| | Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours | Q42023899 |
| | Skin neoplasia in dogs | Q42437816 |
| | Skin neoplasms of dogs in Sydney | Q42512168 |
| | Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium. | Q43632077 |
| | Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs | Q44255955 |
| | Radiation therapy for incompletely resected canine mast cell tumors | Q44869329 |
| | Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). | Q54183893 |
| | Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines. | Q55481478 |
| | Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val | Q57826804 |
| | The prognosis following surgical removal of mastocytomas in dogs | Q67256675 |
| | Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors | Q67565513 |
| | Systemic mastocytosis in 16 dogs | Q68847846 |
| | Neoplasms of the skin and subcutaneous tissues in dogs and cats | Q70013272 |
| | Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs | Q70500186 |
| | Extracutaneous mast-cell tumor in the dog | Q71631725 |
| | A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs | Q71842728 |
| | Prognosis of canine mast cell tumors: a comparison of three methods | Q72563551 |
| | Response of canine mast cell tumors to treatment with oral prednisone | Q72617224 |
| | A new c-kit mutation in a case of aggressive mast cell disease | Q73064152 |
| | c-kit mutation in a population of patients with mastocytosis | Q73295652 |
| | Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors | Q73375267 |
| | Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors | Q73375269 |
| | Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours | Q73540935 |
| | Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999) | Q73797180 |
| | Vincristine therapy for mast cell tumors in dogs | Q74198992 |
| | Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT | Q74291088 |
| | Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision | Q77529529 |
| | Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis | Q77596992 |
| | A Cytologic Comparison of Romanowsky Stains and Papanicolaou-type Stains II. Cytology of Inflammatory and Neoplastic Lesions | Q80451873 |
| | Pathologic survey of 300 extirpated canine mastocytomas | Q93765985 |
| | Mastocytoma and gastroduodenal ulceration. Gastric and duodenal ulcers in dogs with mastocytoma | Q93791883 |
| P433 | issue | 3 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 473-89, v | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Veterinary Clinics of North America: Small Animal Practice | Q15765188 |
| P1476 | title | Mast cell tumors in the dog. | |
| P478 | volume | 33 | |